Narcotics Control Bureau (NCB) has busted an illegal pharma drugs trafficking racket with the arrest of four persons and seized over 55,000 tablets of Zolpidem, abused as drugs, from their possession, the agency said today.
Zolpidem, a sedative medicine, is used to treat sleep disorders and its abuse as narcotic drugs can lead to hallucinations and other side effects.
The central anti-narcotics agency said the alleged racket, where medicines are abused as drugs, was being run using courier services and it brought to the fore "a new modus operandi for trafficking of pharmaceutical drugs through call centres."
The agency, in a statement, said that four accused P Rana, P Bisht, R C Singh and K K Tiwary "acted as drug traffickers and obtained contact numbers of illegal buyers/sellers of phrama drugs from a legal platform available on the internet."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
